NeuroD1-based gene therapy could potentially be used to treat stroke, which is a leading cause of disability in the US, with 800,000 new stroke patients every year
Inhibition of atypical protein kinase C may help manage macular edema and vision loss associated with eye diseases
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.